miRNA as a Biomarker for the Early Detection of Colorectal Cancer
MicroRNAs (miRNAs) are short, non-coding RNA segments that can be detected in a variety of clinical samples, including serum, stool, and urine. While miRNAs were initially known for their effect on post-translational gene expression, the last decade of research has shown them to be promising biomark...
Main Authors: | David Coleman, Scott Kuwada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/15/3/338 |
Similar Items
-
MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer
by: Letizia Masi, et al.
Published: (2022-07-01) -
Temozolomide modulates the expression of miRNAs in colorectal cancer
by: Amany I. Alqosaibi, et al.
Published: (2021-01-01) -
The Role of miRNAs, miRNA Clusters, and isomiRs in Development of Cancer Stem Cell Populations in Colorectal Cancer
by: Victoria A. Stark, et al.
Published: (2021-01-01) -
Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment
by: Marie Rajtmajerová, et al.
Published: (2022-11-01) -
Development of a miRNA‐based classifier for detection of colorectal cancer molecular subtypes
by: Ronja S. Adam, et al.
Published: (2022-07-01)